328 related articles for article (PubMed ID: 33837596)
21. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
Front Immunol; 2022; 13():832394. PubMed ID: 35464491
[TBL] [Abstract][Full Text] [Related]
22. Controlling Cytokine Storm Is Vital in COVID-19.
Tang L; Yin Z; Hu Y; Mei H
Front Immunol; 2020; 11():570993. PubMed ID: 33329533
[TBL] [Abstract][Full Text] [Related]
23. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
Gangemi S; Tonacci A
Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
[TBL] [Abstract][Full Text] [Related]
24. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
Cabler SS; French AR; Orvedahl A
Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
[TBL] [Abstract][Full Text] [Related]
25. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.
Nazerian Y; Ghasemi M; Yassaghi Y; Nazerian A; Hashemi SM
Int Immunopharmacol; 2022 Dec; 113(Pt B):109428. PubMed ID: 36379152
[TBL] [Abstract][Full Text] [Related]
26. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
27. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
29. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N
Cardiorenal Med; 2020; 10(5):277-287. PubMed ID: 32599589
[TBL] [Abstract][Full Text] [Related]
30. Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Stolarski AE; Kim J; Zhang Q; Remick DG
Shock; 2021 Nov; 56(5):667-672. PubMed ID: 34652339
[TBL] [Abstract][Full Text] [Related]
31. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.
Li N; Zhu L; Sun L; Shao G
Stem Cell Res; 2021 Mar; 51():102168. PubMed ID: 33485182
[TBL] [Abstract][Full Text] [Related]
32. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
[TBL] [Abstract][Full Text] [Related]
33. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.
Dziedzic A; Saluk-Bijak J; Miller E; Niemcewicz M; Bijak M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670394
[TBL] [Abstract][Full Text] [Related]
34. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms.
Zheng Y; Li Y; Li M; Wang R; Jiang Y; Zhao M; Lu J; Li R; Li X; Shi S
Med Res Rev; 2024 Mar; 44(2):738-811. PubMed ID: 37990647
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
37. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.
Chen LYC; Biggs CM; Jamal S; Stukas S; Wellington CL; Sekhon MS
Cell Rep Med; 2021 May; 2(5):100269. PubMed ID: 33899032
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
39. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
Ghasemzadeh M; Ghasemzadeh A; Hosseini E
Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
[TBL] [Abstract][Full Text] [Related]
40. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
